Here are 4 biotech stocks that could get a boost from a more open FDA regulatory climate
Biotech-stock investing has one tough test for success - and it's about to get easier ...
Biotech-stock investing has one tough test for success — and it’s about to get easier
Own stocks of companies that get drugs approved. That hasn’t been so easy. But the U.S. Food & Drug Administration (FDA) has ...
Fred Hutch10h
Laying the groundwork for a new cancer-preventive vaccine
Three Fred Hutch Cancer Center researchers received a five-year, $3.8 million award from the National Cancer Institute to ...
sicklecellanemianews13h
Celebrating a milestone in gene therapy for sickle cell disease
Wilson celebrates the first U.S. patient to complete gene therapy for sickle cell, but says advocacy must continue.
Pharmaceutical Technology14h
Intellia’s gene editing therapy shows early potential in rare heart condition
Intellia presented data from its Phase I study of NTLA-2001 at the 2024 American Heart Association scientific meeting in ...
FierceBiotech16h
CSL Behring shuts down California cell and gene therapy R&D site amid group pivot
In another sign of biopharma's waning interest in the traditional ex vivo gene therapy approach, CSL Behring is shutti | CSL ...
2 High-Yield Dividend Stocks I Can't Stop Buying
High-yield dividend stocks have been gaining momentum ahead of potential Fed rate cuts. While sticky inflation and possible ...